Long-Term Study of DISC-1459 for EPP Shows Safety and Efficacy Potential
The study is designed to evaluate the safety, tolerability, and efficacy of DISC-1459 in patients with EPP.
Asset / Drug
Drug and asset intelligence for DISC-1459 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.